These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25109960)

  • 21. [Impact of PI3K /Akt /mdm2 signaling pathway on the sensitivity of gastric cancer cell line SGC7901 to doxorubicin].
    Ai YW; Yu HG; Yu JP; Yang Y; Li H; Hu XW; Luo HS
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):494-7. PubMed ID: 19062713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting phosphoinositide 3-kinase: moving towards therapy.
    Marone R; Cmiljanovic V; Giese B; Wymann MP
    Biochim Biophys Acta; 2008 Jan; 1784(1):159-85. PubMed ID: 17997386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.
    Hill R; Madureira PA; Ferreira B; Baptista I; Machado S; Colaço L; Dos Santos M; Liu N; Dopazo A; Ugurel S; Adrienn A; Kiss-Toth E; Isbilen M; Gure AO; Link W
    Nat Commun; 2017 Mar; 8():14687. PubMed ID: 28276427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akt enhances Mdm2-mediated ubiquitination and degradation of p53.
    Ogawara Y; Kishishita S; Obata T; Isazawa Y; Suzuki T; Tanaka K; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Jun; 277(24):21843-50. PubMed ID: 11923280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
    Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
    Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.
    Singh S; Ramamoorthy M; Vaughan C; Yeudall WA; Deb S; Palit Deb S
    Cell Death Differ; 2013 Apr; 20(4):558-66. PubMed ID: 23238568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression.
    Dung TD; Day CH; Binh TV; Lin CH; Hsu HH; Su CC; Lin YM; Tsai FJ; Kuo WW; Chen LM; Huang CY
    Food Chem Toxicol; 2012 May; 50(5):1802-10. PubMed ID: 22289577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition.
    Lee J; Hong EM; Kim JH; Kim JH; Jung JH; Park SW; Koh DH; Jang HJ
    Mol Biol Rep; 2021 Sep; 48(9):6231-6240. PubMed ID: 34392440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fortifying p53 - beyond Mdm2 inhibitors.
    Sriraman A; Li Y; Dobbelstein M
    Aging (Albany NY); 2016 Sep; 8(9):1836-1837. PubMed ID: 27688014
    [No Abstract]   [Full Text] [Related]  

  • 32. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells.
    Ghorbani A; Jeddi-Tehrani M; Saidpour A; Safa M; Bayat AA; Zand H
    Arch Biochem Biophys; 2015 Jan; 566():58-66. PubMed ID: 25524737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
    Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
    Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship and prognostic significance of phospho-(serine 166)-murine double minute 2 and Akt activation in node-negative breast cancer with regard to p53 expression.
    Schmitz KJ; Grabellus F; Callies R; Wohlschlaeger J; Otterbach F; Kimmig R; Levkau B; Schmid KW; Baba HA
    Virchows Arch; 2006 Jan; 448(1):16-23. PubMed ID: 16208531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability.
    Nam HJ; Chae S; Jang SH; Cho H; Lee JH
    Carcinogenesis; 2010 Sep; 31(9):1531-40. PubMed ID: 20584748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Akt-associated microRNAs.
    Xu M; Mo YY
    Cell Mol Life Sci; 2012 Nov; 69(21):3601-12. PubMed ID: 22936352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3K/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells.
    Jeong SJ; Dasgupta A; Jung KJ; Um JH; Burke A; Park HU; Brady JN
    Virology; 2008 Jan; 370(2):264-72. PubMed ID: 17931677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid hormone induce a p53-dependent DNA damage through PI3K/Akt activation in sperm.
    Xian H; Wang F; Teng W; Yang D; Zhang M
    Gene; 2017 Jun; 615():1-7. PubMed ID: 28322991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting PI3K/Akt signal transduction for cancer therapy.
    He Y; Sun MM; Zhang GG; Yang J; Chen KS; Xu WW; Li B
    Signal Transduct Target Ther; 2021 Dec; 6(1):425. PubMed ID: 34916492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.